1	Signalling	signalling	_	_	_	_	_	_	_
2	via	via	_	_	_	_	_	_	_
3	CD28	cd28	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	human	human	_	_	_	_	_	_	_
6	naive	naive	_	_	_	_	_	_	_
7	neonatal	neonatal	_	_	_	_	_	_	_
8	T	t	_	_	_	_	_	_	_
9	lymphocytes	lymphocyte	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	Accessory	accessory	_	_	_	_	_	_	_
2	molecules	molecule	_	_	_	_	_	_	_
3	play	play	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	crucial	crucial	_	_	_	_	_	_	_
6	role	role	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	development	development	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cell	cell	_	_	_	_	_	_	_
14	response	response	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	antigenic	antigenic	_	_	_	_	_	_	_
17	challenge	challenge	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	examined	examine	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	role	role	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	CD28	cd28	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	modulating	modulate	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	‘	`	_	_	_	_	_	_	_
12	naive	naive	_	_	_	_	_	_	_
13	’	'	_	_	_	_	_	_	_
14	neonatal	neonatal	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	cell	cell	_	_	_	_	_	_	_
17	response	response	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	anti-CD2-mediated	anti-cd2-mediated	_	_	_	_	_	_	_
20	activation	activation	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	compare	compare	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	role	role	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	CD28	cd28	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	neonatal	neonatal	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	adult	adult	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	were	be	_	_	_	_	_	_	_
14	stimulated	stimulate	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	pair	pair	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	mitogenic	mitogenic	_	_	_	_	_	_	_
20	anti-CD2	anti-cd2	_	_	_	_	_	_	_
21	antibodies	antibody	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	presence	presence	_	_	_	_	_	_	_
25	or	or	_	_	_	_	_	_	_
26	absence	absence	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	anti-CD28	anti-cd28	_	_	_	_	_	_	_
29	MoAb	MoAb	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	With	with	_	_	_	_	_	_	_
2	anti-CD2	anti-cd2	_	_	_	_	_	_	_
3	alone	alone	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	neonatal	neonatal	_	_	_	_	_	_	_
6	T	t	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	proliferated	proliferate	_	_	_	_	_	_	_
9	slightly	slightly	_	_	_	_	_	_	_
10	but	but	_	_	_	_	_	_	_
11	produced	produce	_	_	_	_	_	_	_
12	no	no	_	_	_	_	_	_	_
13	detectable	detectable	_	_	_	_	_	_	_
14	IL-2	il-2	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	whereas	whereas	_	_	_	_	_	_	_
17	adult	adult	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	proliferated	proliferate	_	_	_	_	_	_	_
21	vigorously	vigorously	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	significant	significant	_	_	_	_	_	_	_
25	IL-2	il-2	_	_	_	_	_	_	_
26	production	production	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Costimulation	costimulation	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	anti-CD28	anti-cd28	_	_	_	_	_	_	_
4	MoAb	MoAb	_	_	_	_	_	_	_
5	greatly	greatly	_	_	_	_	_	_	_
6	enhanced	enhance	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	proliferative	proliferative	_	_	_	_	_	_	_
9	response	response	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	neonatal	neonatal	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	levels	level	_	_	_	_	_	_	_
16	equivalent	equivalent	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	those	those	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	adult	adult	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	whereas	whereas	_	_	_	_	_	_	_
25	adult	adult	_	_	_	_	_	_	_
26	T	t	_	_	_	_	_	_	_
27	cells	cell	_	_	_	_	_	_	_
28	showed	show	_	_	_	_	_	_	_
29	only	only	_	_	_	_	_	_	_
30	slight	slight	_	_	_	_	_	_	_
31	increases	increase	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	IL-2	il-2	_	_	_	_	_	_	_
3	secretion	secretion	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	increased	increase	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	presence	presence	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	anti-CD28	anti-cd28	_	_	_	_	_	_	_
11	MoAb	MoAb	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	neonatal	neonatal	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cell	cell	_	_	_	_	_	_	_
16	IL-2	il-2	_	_	_	_	_	_	_
17	production	production	_	_	_	_	_	_	_
18	remained	remain	_	_	_	_	_	_	_
19	lower	low	_	_	_	_	_	_	_
20	than	than	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	adults	adult	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	enhancement	enhancement	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	IL-2	il-2	_	_	_	_	_	_	_
7	mRNA	mrna	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	neonates	neonate	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	similar	similar	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	adult	adult	_	_	_	_	_	_	_
15	levels	level	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Anti-CD28	anti-cd28	_	_	_	_	_	_	_
2	MoAb	MoAb	_	_	_	_	_	_	_
3	costimulation	costimulation	_	_	_	_	_	_	_
4	increased	increase	_	_	_	_	_	_	_
5	NF	NF	_	_	_	_	_	_	_
6	kappa	kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	levels	level	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	neonates	neonate	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	albeit	albeit	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	levels	level	_	_	_	_	_	_	_
15	lower	low	_	_	_	_	_	_	_
16	than	than	_	_	_	_	_	_	_
17	that	that	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	adults	adult	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	cellular	cellular	_	_	_	_	_	_	_
3	mechanism	mechanism	_	_	_	_	_	_	_
4	governing	govern	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	diminished	diminish	_	_	_	_	_	_	_
7	proliferative	proliferative	_	_	_	_	_	_	_
8	response	response	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	neonatal	neonatal	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	lymphocytes	lymphocyte	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	anti-CD2	anti-cd2	_	_	_	_	_	_	_
15	may	may	_	_	_	_	_	_	_
16	therefore	therefore	_	_	_	_	_	_	_
17	be	be	_	_	_	_	_	_	_
18	due	due	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	decreased	decrease	_	_	_	_	_	_	_
21	NF	NF	_	_	_	_	_	_	_
22	kappa	kappa	_	_	_	_	_	_	_
23	B	B	_	_	_	_	_	_	_
24	induction	induction	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	reduced	reduce	_	_	_	_	_	_	_
27	IL-2	il-2	_	_	_	_	_	_	_
28	mRNA	mrna	_	_	_	_	_	_	_
29	expression	expression	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	deficient	deficient	_	_	_	_	_	_	_
32	IL-2	il-2	_	_	_	_	_	_	_
33	production	production	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	anti-CD28	anti-cd28	_	_	_	_	_	_	_
3	MoAb	MoAb	_	_	_	_	_	_	_
4	costimulation	costimulation	_	_	_	_	_	_	_
5	enhances	enhance	_	_	_	_	_	_	_
6	all	all	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	above	above	_	_	_	_	_	_	_
10	signals	signal	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	NF	NF	_	_	_	_	_	_	_
13	kappa	kappa	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	IL-2	il-2	_	_	_	_	_	_	_
17	levels	level	_	_	_	_	_	_	_
18	remain	remain	_	_	_	_	_	_	_
19	lower	low	_	_	_	_	_	_	_
20	than	than	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	adults	adult	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	suggesting	suggest	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	need	need	_	_	_	_	_	_	_
27	for	for	_	_	_	_	_	_	_
28	further	further	_	_	_	_	_	_	_
29	activation	activation	_	_	_	_	_	_	_
30	requirements	requirement	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	neonate	neonate	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

